Pacira | PCRX - Assets


Pacira reported $1.24B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Astellas Pharma JPY 3.69T 125.48B Jun/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Cara Therapeutics USD 25.82M 6.26M Mar/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Heron Therapeutics USD 252.26M 6.05M Jun/2026
Ironwood Pharmaceuticals USD 434.57M 37.66M Mar/2026
J&J USD 201.06B 167M Jun/2026
Ligand Pharmaceuticals USD 2.19B 653.77M Jun/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Novo Nordisk DKK 594.94B 35.72B Jun/2026
Omeros USD 200.57M 34.59M Jun/2025
Pacira USD 1.24B 35.44M Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Supernus Pharmaceuticals USD 1.43B 72.62M Jun/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
Xeris Pharmaceuticals USD 411.9M 19.89M Jun/2026
Zoetis USD 15.08B 77M Jun/2026